{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:26:59Z","timestamp":1648837619461},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1157\/13106853","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T12:48:41Z","timestamp":1182516521000},"page":"298-300","source":"Crossref","is-referenced-by-count":1,"title":["Estado actual del tratamiento de la enfermedad inflamatoria intestinal"],"prefix":"10.1016","volume":"207","author":[{"given":"A.","family":"L\u00f3pez San Rom\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rivero Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1157\/13106853_bib1","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1136\/gut.2005.081950b","article-title":"European Crohn\u2019s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: current management","volume":"55","author":"Travis","year":"2006","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1157\/13106853_bib2","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European Crohn\u2019s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut."},{"issue":"Suppl 5","key":"10.1157\/13106853_bib3","doi-asserted-by":"crossref","first-page":"V1","DOI":"10.1136\/gut.2004.043372","article-title":"British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"10.1157\/13106853_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/gast.2001.26279","article-title":"The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study","volume":"121","author":"Faubion","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1157\/13106853_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2036.2006.02974.x","article-title":"The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort","volume":"24","author":"Ho","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13106853_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/gut.35.3.360","article-title":"Frequency of glucocorticoid resistance and dependency in Crohn\u2019s disease","volume":"35","author":"Munkholm","year":"1994","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1157\/13106853_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2036.2006.03066.x","article-title":"Review article: biological drugs in Crohn\u2019s disease","volume":"24","author":"Kamm","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13106853_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090316","article-title":"Emerging biological treatments in inflammatory bowel diseases","volume":"24","author":"Van Assche","year":"2006","journal-title":"Dig Dis"},{"issue":"Suppl 1","key":"10.1157\/13106853_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000089781","article-title":"Inflammatory bowel disease: current therapeutic options","volume":"73","author":"Dom\u00e8nech","year":"2006","journal-title":"Digestion"},{"key":"10.1157\/13106853_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1053\/j.gastro.2006.02.038","article-title":"Infliximab and azathioprine: bridge or parachute?","volume":"130","author":"Travis","year":"2006","journal-title":"Gastroente rology"},{"issue":"Suppl 4","key":"10.1157\/13106853_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2036.2004.02050.x","article-title":"Review article: the role of nutrition in the treatment of inflammatory bowel disease","volume":"20","author":"Gassull","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13106853_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/00042737-200603000-00004","article-title":"Optimizing quality of outpatient care for patients with inflammatory bowel disease: the importance of specialist clinics","volume":"18","author":"Mawdsley","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 3","key":"10.1157\/13106853_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2036.2006.03060.x","article-title":"Review article: how to control and improve adherence to therapy in inflammatory bowel disease","volume":"24","author":"L\u00f3pez-Sanrom\u00e1n","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1157\/13106853_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1157\/13090520","article-title":"\u00bfAdhesi\u00f3n al tratamiento, adherencia al tratamiento o cumplimiento del tratamiento?","volume":"206","author":"L\u00f3pez San Rom\u00e1n","year":"2006","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13106853_bib15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/gut.2004.060103","article-title":"Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild\/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study","volume":"54","author":"Marteau","year":"2005","journal-title":"Gut"},{"issue":"Suppl 3","key":"10.1157\/13106853_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2036.2006.03064.x","article-title":"Review article: saving the colon in severe colitis - the case for medical therapy","volume":"24","author":"Travis","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13106853_bib17","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Inliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13106853_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/gut.2005.078055","article-title":"Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?","volume":"55","author":"Sands","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1157\/13106853_bib19","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","author":"Sutherland","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1157\/13106853_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2036.18.s2.3.x","article-title":"Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease","volume":"18","author":"Eaden","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13106853_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"10.1157\/13106853_bib22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2036.2006.02786.x","article-title":"Review article: Infliximab the rapy for inflammatory bowel diseaseseven years on","volume":"23","author":"Rutgeerts","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13106853_bib23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"10.1157\/13106853_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0014-2565(02)71143-0","article-title":"Terapia individualizada con azatioprina o 6-mercaptopurina mediante monitorizaci\u00f3n de la actividad de la tiopurina metiltransferasa (TPMT)","volume":"202","author":"Gisbert","year":"2002","journal-title":"Rev Clin Esp"},{"key":"10.1157\/13106853_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2006.02.014","article-title":"Infliximab plus azathioprine for steroid-dependent Crohn\u2019s disease patients: a randomized placebo-controlled trial","volume":"130","author":"L\u00e9mann","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1157\/13106853_bib26","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"AGA technical review on perianal Crohn\u2019s disease","volume":"125","author":"Sandborn","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1157\/13106853_bib27","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1053\/j.gastro.2006.01.048","article-title":"American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease","volume":"130","author":"Lichtenstein","year":"2006","journal-title":"Gastroenterology"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001425650773388X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001425650773388X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T13:23:05Z","timestamp":1546780985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001425650773388X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S001425650773388X"],"URL":"https:\/\/doi.org\/10.1157\/13106853","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}